These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 20406393

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR, Liu XP, Li JW.
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [Abstract] [Full Text] [Related]

  • 4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Aug; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, Deku JG, Kasu ES, Mensah P, Agede CY, Dodoo C, Asiamah EA, Tampuori J, Korbuvi J, Opintan JA.
    BMC Pregnancy Childbirth; 2020 May 06; 20(1):266. PubMed ID: 32375724
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP, da Silva MC, Paiva LC, Svidzinski TI, Consolaro ME.
    Acta Derm Venereol; 2012 Jan 06; 92(1):78-82. PubMed ID: 21918792
    [Abstract] [Full Text] [Related]

  • 12. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A, HIV Epidemiology Research Study (HERS) Group.
    J Infect Dis; 2001 Jan 15; 183(2):286-93. PubMed ID: 11204125
    [Abstract] [Full Text] [Related]

  • 13. [Combined single-day treatment in acute vulvovaginal candidosis].
    Kovachev S, Nacheva A, Vacheva-Dobrevska R, Vasilev N.
    Akush Ginekol (Sofiia); 2009 Jan 15; 48(6):18-23. PubMed ID: 20225492
    [Abstract] [Full Text] [Related]

  • 14. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA, Mukhopadhyay G, Banerjee U, Goswami R, Prasad R.
    J Microbiol Immunol Infect; 2011 Jun 15; 44(3):166-71. PubMed ID: 21524609
    [Abstract] [Full Text] [Related]

  • 15. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M, Schaller M, Weissenbacher ER.
    Mycoses; 2015 Mar 15; 58 Suppl 1():1-15. PubMed ID: 25711406
    [Abstract] [Full Text] [Related]

  • 16. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D, Goswami R, Dadhwal V, Goswami D, Banerjee U, Kochupillai N.
    J Infect; 2007 Oct 15; 55(4):374-7. PubMed ID: 17692922
    [Abstract] [Full Text] [Related]

  • 17. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC, Camponovo R, Araya I, Cerda A, Santander MP, Carrillo-Muñoz AJ.
    Rev Esp Quimioter; 2016 Jun 15; 29(3):151-4. PubMed ID: 27167765
    [Abstract] [Full Text] [Related]

  • 18. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z, Sobel JD.
    Diagn Microbiol Infect Dis; 2009 Jul 15; 64(3):354-6. PubMed ID: 19501794
    [Abstract] [Full Text] [Related]

  • 19. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
    Zhu Y, Shan Y, Fan S, Li J, Liu X.
    Mycopathologia; 2015 Feb 15; 179(1-2):111-8. PubMed ID: 25322705
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y, Chen L, Li C.
    J Antimicrob Chemother; 2008 Apr 15; 61(4):798-804. PubMed ID: 18218640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.